<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="188175">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00643942</url>
  </required_header>
  <id_info>
    <org_study_id>C-06-23</org_study_id>
    <nct_id>NCT00643942</nct_id>
  </id_info>
  <brief_title>Staining in a Healthy, Non-Dry Eye Population</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The clinical objective of this study is to quantify the levels of corneal and conjunctival
      staining in a healthy, non-dry eye population. This is a descriptive study without test
      article administered.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <primary_completion_date type="Actual">January 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Corneal fluorescein staining scores</measure>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment>120</enrollment>
  <condition>Normal Healthy Eyes</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention required</intervention_name>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with normal healthy eyes
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy eyes

        Exclusion Criteria:

          -  Age related
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2008</verification_date>
  <lastchanged_date>May 8, 2015</lastchanged_date>
  <firstreceived_date>March 24, 2008</firstreceived_date>
  <responsible_party>
    <name_title>Judy Vittitoe</name_title>
    <organization>Alcon</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
